Meina Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Meina Wang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Hongqiu Cui
Key Laboratory of National Forestry and Grassland Administration for Orchid Conservation and Utilization (Shenzhen), Shenzhen 518114, People’s Republic of China
2 shared publicationsMeili Zhao
Key Laboratory of National Forestry and Grassland Administration for Orchid Conservation and Utilization (Shenzhen), Shenzhen 518114, People’s Republic of China
2 shared publications- Zhicai Wang
Shenzhen Key Laboratory for Orchid Conservation and Utilization, The National Orchid Conservation Center of China and The Orchid Conservation & Research Center of Shenzhen, Shenzhen 518114, China
2 shared publications - Hui Shen
Eastern China Conservation Centre for Wild Endangered Plant Resources, Shanghai Chenshan Botanical Garden, Shanghai, China
1 shared publication Jian Li
Key Laboratory of National Forestry and Grassland Administration for Orchid Conservation and Utilization, Shenzhen, China
1 shared publication- Jian Li
The Orchid Conservation & Research Center of Shenzhen and the National Orchid Conservation Center of China, Shenzhen Key Laboratory for Orchid Conservation and Utilization, Key Laboratory of National Forestry and Grassland Administration on Dendrobium Officinale, Shenzhen 518114, China
1 shared publication
Latest Publications
- Open Access
- 6 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (9) , 4149
Chemical Constituents, Pharmacological Activities, and Cardiovascular Protective Mechanisms of Dendrobium Species: A Review
The genus Dendrobium, a well-known traditional Chinese medicinal herb, contains complex and diverse chemical constituents. The plant has been widely used in traditional medicine and has attracted increasing attention in modern pharmacological research due to its therapeutic potential. Bibliographic searches were conducted across various recognized databases. The exploration covered the years 1965–2025, and the connectors ‘and’ and ‘or’ were used with keywords such as “Dendrobium”, “phytochemistry”, “pharmacology”, “Cardiovascular diseases”, and “extracts”. The chemical composition of the genus Dendrobium mainly includes alkaloids, bibenzyls, flavonoids, phenanthrenes, phenylpropanoids, and terpenoids. Modern pharmacological studies have demonstrated that the genus Dendrobium exhibits multiple biological effects, including anti-tumor, antibacterial, anti-inflammatory, hypoglycemic, and neuroprotective activities. Notably, the genus Dendrobium shows significant potential in cardiovascular disease prevention and treatment through mechanisms such as antioxidant stress, anti-inflammation, regulation of lipid metabolism, anti-atherosclerosis, and inhibition of myocardial fibrosis. This review provides a comprehensive overview of the chemical components and pharmacological activities of Dendrobium plants, with emphasis on their cardiovascular protective effects. These findings offer a scientific basis for the further development and clinical application of Dendrobium medicinal resources.
- 6 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (9) , 4149
Open AccessChemical Constituents, Pharmacological Activities, and Cardiovascular Protective Mechanisms of Dendrobium Species: A Review
The genus Dendrobium, a well-known traditional Chinese medicinal herb, contains complex and diverse chemical constituents. The plant has been widely used in traditional medicine and has attracted increasing attention in modern pharmacological research due to its therapeutic potential. Bibliographic searches were conducted across various recognized databases. The exploration covered the years 1965–2025, and the connectors ‘and’ and ‘or’ were used with keywords such as “Dendrobium”, “phytochemistry”, “pharmacology”, “Cardiovascular diseases”, and “extracts”. The chemical composition of the genus Dendrobium mainly includes alkaloids, bibenzyls, flavonoids, phenanthrenes, phenylpropanoids, and terpenoids. Modern pharmacological studies have demonstrated that the genus Dendrobium exhibits multiple biological effects, including anti-tumor, antibacterial, anti-inflammatory, hypoglycemic, and neuroprotective activities. Notably, the genus Dendrobium shows significant potential in cardiovascular disease prevention and treatment through mechanisms such as antioxidant stress, anti-inflammation, regulation of lipid metabolism, anti-atherosclerosis, and inhibition of myocardial fibrosis. This review provides a comprehensive overview of the chemical components and pharmacological activities of Dendrobium plants, with emphasis on their cardiovascular protective effects. These findings offer a scientific basis for the further development and clinical application of Dendrobium medicinal resources.
- Open Access
Whole Genome Duplication Events Likely Contributed to the Aquatic Adaptive Evolution of Parkerioideae
As the only aquatic lineage of Pteridaceae, Parkerioideae is distinct from many xeric-adapted species of the family and consists of the freshwater Ceratopteris species and the only mangrove ferns from the genus Acrostichum. Previous studies have shown that whole genome duplication (WGD) has occurred in Parkerioideae at least once and may have played a role in their adaptive evolution; however, more in-depth research regarding this is still required. In this study, comparative and evolutionary transcriptomics analyses were carried out to identify WGDs and explore their roles in the environmental adaptation of Parkerioideae. Three putative WGD events were identified within Parkerioideae, two of which were specific to Ceratopteris and Acrostichum, respectively. The functional enrichment analysis indicated that the lineage-specific WGD events have played a role in the adaptation of Parkerioideae to the low oxygen concentrations of aquatic habitats, as well as different aquatic environments of Ceratopteris and Acrostichum, such as the adaptation of Ceratopteris to reduced light levels and the adaptation of Acrostichum to high salinity. Positive selection analysis further provided evidence that the putative WGD events may have facilitated the adaptation of Parkerioideae to changes in habitat. Moreover, the gene family analysis indicated that the plasma membrane H+-ATPase (AHA), vacuolar H+-ATPase (VHA), and suppressor of K+ transport growth defect 1 (SKD1) may have been involved in the high salinity adaptation of Acrostichum. Our study provides new insights into the evolution and adaptations of Parkerioideae in different aquatic environments.
Open AccessWhole Genome Duplication Events Likely Contributed to the Aquatic Adaptive Evolution of Parkerioideae
As the only aquatic lineage of Pteridaceae, Parkerioideae is distinct from many xeric-adapted species of the family and consists of the freshwater Ceratopteris species and the only mangrove ferns from the genus Acrostichum. Previous studies have shown that whole genome duplication (WGD) has occurred in Parkerioideae at least once and may have played a role in their adaptive evolution; however, more in-depth research regarding this is still required. In this study, comparative and evolutionary transcriptomics analyses were carried out to identify WGDs and explore their roles in the environmental adaptation of Parkerioideae. Three putative WGD events were identified within Parkerioideae, two of which were specific to Ceratopteris and Acrostichum, respectively. The functional enrichment analysis indicated that the lineage-specific WGD events have played a role in the adaptation of Parkerioideae to the low oxygen concentrations of aquatic habitats, as well as different aquatic environments of Ceratopteris and Acrostichum, such as the adaptation of Ceratopteris to reduced light levels and the adaptation of Acrostichum to high salinity. Positive selection analysis further provided evidence that the putative WGD events may have facilitated the adaptation of Parkerioideae to changes in habitat. Moreover, the gene family analysis indicated that the plasma membrane H+-ATPase (AHA), vacuolar H+-ATPase (VHA), and suppressor of K+ transport growth defect 1 (SKD1) may have been involved in the high salinity adaptation of Acrostichum. Our study provides new insights into the evolution and adaptations of Parkerioideae in different aquatic environments.
- Open Access
- 1 November 2020
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 13, 11337-11346
Gigantol Attenuates the Metastasis of Human Bladder Cancer Cells, Possibly Through Wnt/EMT Signaling
Background: Bladder cancer has long been recognized as one of the most common and aggressive human malignant carcinomas due to the increased invasiveness and metastasis. The discovery and development of natural compounds from Dendrobium species for cancer therapy have garnered increasing attention in recent years. Among those natural elements, the bibenzyl compound gigantol has promising therapeutic potential against several cancer cell lines; however, its roles on bladder tumor metastasis have not been investigated. Materials and Methods: Here in this in vitro study, we utilized viability tests, cell migration, cell invasion and apoptosis assays to evaluate the anti-tumor activity of gigantol on three human bladder cancer cell lines (SW780, 5637, and T24) and a normal human bladder cell line (SVHUC-1). Cells were treated with different concentrations of gigantol (0, 40, 80, and 160 μM) for 24, 48 and 72 h. Results: Here in this study, we showed that gigantol suppressed cancer cell proliferation but not normal SVHUC-1 cells. The inhibitory effect of the compound on cell migration and invasion was also exhibited in the cancer cell lines. Cell apoptosis assay by flow cytometry revealed enhanced apoptotic effects of gigantol on cancer cells. Gene expression analysis revealed that Wnt/EMT signaling might involve in the response of bladder cancer cells to gigantol. Conclusion: Therefore, the present data demonstrate gigantol as a strong anticancer reagent against bladder cancer possibly through Wnt/EMT signaling.
- 1 November 2020
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 13, 11337-11346
Open AccessGigantol Attenuates the Metastasis of Human Bladder Cancer Cells, Possibly Through Wnt/EMT Signaling
Background: Bladder cancer has long been recognized as one of the most common and aggressive human malignant carcinomas due to the increased invasiveness and metastasis. The discovery and development of natural compounds from Dendrobium species for cancer therapy have garnered increasing attention in recent years. Among those natural elements, the bibenzyl compound gigantol has promising therapeutic potential against several cancer cell lines; however, its roles on bladder tumor metastasis have not been investigated. Materials and Methods: Here in this in vitro study, we utilized viability tests, cell migration, cell invasion and apoptosis assays to evaluate the anti-tumor activity of gigantol on three human bladder cancer cell lines (SW780, 5637, and T24) and a normal human bladder cell line (SVHUC-1). Cells were treated with different concentrations of gigantol (0, 40, 80, and 160 μM) for 24, 48 and 72 h. Results: Here in this study, we showed that gigantol suppressed cancer cell proliferation but not normal SVHUC-1 cells. The inhibitory effect of the compound on cell migration and invasion was also exhibited in the cancer cell lines. Cell apoptosis assay by flow cytometry revealed enhanced apoptotic effects of gigantol on cancer cells. Gene expression analysis revealed that Wnt/EMT signaling might involve in the response of bladder cancer cells to gigantol. Conclusion: Therefore, the present data demonstrate gigantol as a strong anticancer reagent against bladder cancer possibly through Wnt/EMT signaling.
- Open Access
- 28 April 2020
- Published by Frontiers Media SA in Frontiers in Plant Science
- Vol. 11, 391
Transcriptomic Landscape of Medicinal Dendrobium Reveals Genes Associated With the Biosynthesis of Bioactive Components
Many plants of Dendrobium genus are precious traditional herbs with high commercial value and excellent medicinal effects. They are perennial aerophytes or epiphytes of terrestrial orchids growing on cliffs and tree trunks covered with mosses in forests throughout the tropical and subtropical Asia and eastern Australia. The stem contains a variety of bioactive components, including polysaccharides and alkaloids, with strong antioxidant, neuroprotective, and immunomodulatory effects. Great attention has been drawn to the Dendrobium genus regarding its medicinal effectiveness, and the related researches have been accumulating rapidly in recent years. The bioactive components are mainly the intermediates or final products produced in specialized metabolite biosynthesis. Thus far, the activity, molecular structure, and composition of major medicinal ingredients have been partially elucidated, and the sequencing of several transcriptomes has been starting to shed new light on the biosynthesis regulation mechanism. This paper reviewed the advances of researches concerning the biosynthetic pathways of medicinal specialized metabolites from Dendrobium, especially the large number of related genes, with the hope of further promoting the development and utilization of those components and correspondingly protecting the Dendrobium resources in more effective ways.
- 28 April 2020
- Published by Frontiers Media SA in Frontiers in Plant Science
- Vol. 11, 391
Open AccessTranscriptomic Landscape of Medicinal Dendrobium Reveals Genes Associated With the Biosynthesis of Bioactive Components
Many plants of Dendrobium genus are precious traditional herbs with high commercial value and excellent medicinal effects. They are perennial aerophytes or epiphytes of terrestrial orchids growing on cliffs and tree trunks covered with mosses in forests throughout the tropical and subtropical Asia and eastern Australia. The stem contains a variety of bioactive components, including polysaccharides and alkaloids, with strong antioxidant, neuroprotective, and immunomodulatory effects. Great attention has been drawn to the Dendrobium genus regarding its medicinal effectiveness, and the related researches have been accumulating rapidly in recent years. The bioactive components are mainly the intermediates or final products produced in specialized metabolite biosynthesis. Thus far, the activity, molecular structure, and composition of major medicinal ingredients have been partially elucidated, and the sequencing of several transcriptomes has been starting to shed new light on the biosynthesis regulation mechanism. This paper reviewed the advances of researches concerning the biosynthetic pathways of medicinal specialized metabolites from Dendrobium, especially the large number of related genes, with the hope of further promoting the development and utilization of those components and correspondingly protecting the Dendrobium resources in more effective ways.